Literature DB >> 7800167

Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms.

G K Kirov1, N J Birch, P Steadman, R G Ramsey.   

Abstract

Plasma magnesium levels were tested in a group of 155 psychiatric in-patients with a variety of diagnoses and were correlated with the severity of their symptoms. We hypothesized that lower Mg levels would correlate with a higher degree of anxiety, tiredness and other symptoms characteristic of Mg deficiency. No such correlations were observed. However, Mg levels varied widely, with 22.4% below, and 10.4% above the normal range. There was a strong association for more disturbed and excitable patients to have abnormal (either high or low) levels. We speculate that more disturbed patients might have some abnormality of Mg metabolism with possible therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800167     DOI: 10.1159/000119139

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

1.  Features of central neurotransmission in animals in conditions of dietary magnesium deficiency and after its correction.

Authors:  A A Spasov; I N Iezhitsa; M S Kravchenko; M V Kharitonova
Journal:  Neurosci Behav Physiol       Date:  2009-07-21

2.  Modulation of antidepressant-like activity of magnesium by serotonergic system.

Authors:  E Poleszak
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

3.  Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.

Authors:  Bartlomiej Pochwat; Magdalena Sowa-Kucma; Katarzyna Kotarska; Paulina Misztak; Gabriel Nowak; Bernadeta Szewczyk
Journal:  Psychopharmacology (Berl)       Date:  2014-07-16       Impact factor: 4.530

Review 4.  Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines.

Authors:  Mervin Chávez-Castillo; Victoria Núñez; Manuel Nava; Ángel Ortega; Milagros Rojas; Valmore Bermúdez; Joselyn Rojas-Quintero
Journal:  Adv Pharmacol Sci       Date:  2019-01-03

5.  The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis.

Authors:  Hussein Kadhem Al-Hakeim; Ali Fattah Al-Musawi; Abbas Al-Mulla; Arafat Hussein Al-Dujaili; Monojit Debnath; Michael Maes
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

6.  A retrospective analysis of biochemical and haematological parameters in patients with eating disorders.

Authors:  Leanne J Barron; Robert F Barron; Jeremy C S Johnson; Ingrid Wagner; Cameron J B Ward; Shannon R B Ward; Faye M Barron; Warren K Ward
Journal:  J Eat Disord       Date:  2017-10-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.